共 50 条
- [31] Antiviral Efficacy of Pralatrexate against SARS-CoV-2BIOMOLECULES & THERAPEUTICS, 2021, 29 (03) : 268 - 272论文数: 引用数: h-index:机构:Lee, Gee Eun论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South KoreaPark, Heedo论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South KoreaCho, Juyoung论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South KoreaKim, Jeonghun论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea论文数: 引用数: h-index:机构:Kim, Kisoon论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South KoreaKim, Jin Il论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Biosafety Ctr, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South KoreaPark, Man-Seong论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea Korea Univ, Biosafety Ctr, Coll Med, Seoul 02841, South Korea Korea Univ, Inst Viral Dis, Dept Microbiol, Coll Med, Seoul 02841, South Korea
- [32] Innate immune recognition against SARS-CoV-2Inflammation and Regeneration, 43Taisho Yamada论文数: 0 引用数: 0 h-index: 0机构: Hokkaido University,Division of Signaling in Cancer and Immunology, Institute for Genetic MedicineAkinori Takaoka论文数: 0 引用数: 0 h-index: 0机构: Hokkaido University,Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine
- [33] Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variantsJOURNAL OF VIROLOGY, 2023, 97 (11)Wu, Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaShi, Jian论文数: 0 引用数: 0 h-index: 0机构: Wuhan YZY Biopharma Co Ltd, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaHe, Xiaoxue论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaLu, Jia论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Univ Chinese Acad Sci, Beijing, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaGao, Xiao论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Univ Chinese Acad Sci, Beijing, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaZhu, Xuerui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaChen, Xinlan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Univ Chinese Acad Sci, Beijing, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaZhang, Man论文数: 0 引用数: 0 h-index: 0机构: Wuhan YZY Biopharma Co Ltd, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaFang, Lijuan论文数: 0 引用数: 0 h-index: 0机构: Wuhan YZY Biopharma Co Ltd, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaZhang, Jing论文数: 0 引用数: 0 h-index: 0机构: Wuhan YZY Biopharma Co Ltd, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaYuan, Zhiming论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Univ Chinese Acad Sci, Beijing, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaXiao, Gengfu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Univ Chinese Acad Sci, Beijing, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaZhou, Pengfei论文数: 0 引用数: 0 h-index: 0机构: Wuhan YZY Biopharma Co Ltd, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R ChinaPan, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China Univ Chinese Acad Sci, Beijing, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, Wuhan, Peoples R China Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China
- [34] Antidiabetes Agents against Sars-Cov-2 InfectionSN Comprehensive Clinical Medicine, 2020, 2 (12) : 2718 - 2721Antonio Vitiello论文数: 0 引用数: 0 h-index: 0机构: Pharmaceutical Department,Francesco Ferrara论文数: 0 引用数: 0 h-index: 0机构: Pharmaceutical Department,
- [35] Natural and vaccine-induced immunity are equivalent for the protection against SARS-CoV-2 infectionJOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (08) : 1137 - 1141论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Cereda, Danilo论文数: 0 引用数: 0 h-index: 0机构: Directorate Gen Hlth, Milan, Italy Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, ItalyBortolan, Francesco论文数: 0 引用数: 0 h-index: 0机构: Directorate Gen Hlth, Milan, Italy Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, ItalyLeoni, Olivia论文数: 0 引用数: 0 h-index: 0机构: Directorate Gen Hlth, Milan, Italy Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, ItalyPavesi, Giovanni论文数: 0 引用数: 0 h-index: 0机构: Directorate Gen Hlth, Milan, Italy Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, ItalyGalli, Massimo论文数: 0 引用数: 0 h-index: 0机构: Luigi Sacco Hosp, Infect Dis Unit, Milan, Italy Univ Milan, Dept Biomed & Clin Sci, Milan, Italy Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, ItalyValenti, Giuseppina论文数: 0 引用数: 0 h-index: 0机构: Directorate Gen Hlth, Milan, Italy Univ Milano Bicocca, Natl Ctr Healthcare Res & Pharmacoepidemiol, Milan, Italy论文数: 引用数: h-index:机构:
- [36] Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2CELL DISCOVERY, 2022, 8 (01)Liang, Yu论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZhang, Jing论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaYuan, Run Yu论文数: 0 引用数: 0 h-index: 0机构: Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaWang, Mei Yu论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaHe, Peng论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaSu, Ji Guo论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaHan, Zi Bo论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaJin, Yu Qin论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaHou, Jun Wei论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZhang, Hao论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZhang, Xue Feng论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaShao, Shuai论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaHou, Ya Nan论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaLiu, Zhao Ming论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaDu, Li Fang论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaShen, Fu Jie论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZhou, Wei Min论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaXu, Ke论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaGao, Ru Qin论文数: 0 引用数: 0 h-index: 0机构: Qingdao Ctr Dis Control & Prevent, Qingdao, Shandong, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaTang, Fang论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaLei, Ze Hua论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaLiu, Shuo论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZhen, Wei论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaWu, Jin Juan论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZheng, Xiang论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaLiu, Ning论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaChen, Shi论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaMa, Zhi Jing论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaZheng, Fan论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaRen, Si Yu论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaHu, Zhong Yu论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaHuang, Wei Jin论文数: 0 引用数: 0 h-index: 0机构: Natl Inst Food & Drug Control NIFDC, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaWu, Gui Zhen论文数: 0 引用数: 0 h-index: 0机构: Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaKe, Chang Wen论文数: 0 引用数: 0 h-index: 0机构: Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R ChinaLi, Qi Ming论文数: 0 引用数: 0 h-index: 0机构: Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China Natl Engn Ctr New Vaccine Res, Beijing, Peoples R China Natl Vaccine & Serum Inst NVSI, Lab 6, Beijing, Peoples R China
- [37] Lung directed antibody gene transfer confers protection against SARS-CoV-2 infectionTHORAX, 2022, 77 (12) : 1229 - 1236Du, Yue论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandMiah, Kamran M.论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Conway, Catriona C.论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandViegas, Mariana A.论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandDean, Rebecca论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandSatyapertiwi, Dwiantari论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandZhao, Jincun论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandWang, Yanqun论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandTemperton, Nigel J.论文数: 0 引用数: 0 h-index: 0机构: Univ Kent, Medway Sch Pharm, Canterbury, Kent, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandGamlen, Toby P. E.论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandGill, Deborah R.论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, EnglandHyde, Stephen C.论文数: 0 引用数: 0 h-index: 0机构: Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England Univ Oxford, Radcliffe Dept Med, NDCLS, Oxford, Oxon, England
- [38] Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variantsBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 746Du, Shuang论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R ChinaYang, Liu论文数: 0 引用数: 0 h-index: 0机构: Nanjing Shenxin Biotechnol Co Ltd, Nanjing 211800, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R ChinaChen, Xingguang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Shenxin Biotechnol Co Ltd, Nanjing 211800, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R ChinaChen, Yonghao论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R ChinaWeng, Liang论文数: 0 引用数: 0 h-index: 0机构: Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R ChinaHuang, Hui论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, Coll Engn, Natl R&D Ctr Chinese Herbal Med Proc, State Key Lab Nat Med, Nanjing 211109, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R ChinaPang, Silin论文数: 0 引用数: 0 h-index: 0机构: Nanjing Shenxin Biotechnol Co Ltd, Nanjing 211800, Peoples R China Shenzhen Shenxin Biotechnol Co Ltd, Shenzhen 518052, Peoples R China
- [39] On the Efficacy of ZnO Nanostructures against SARS-CoV-2INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)Sportelli, Maria Chiara论文数: 0 引用数: 0 h-index: 0机构: Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, ItalyIzzi, Margherita论文数: 0 引用数: 0 h-index: 0机构: Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, ItalyLoconsole, Daniela论文数: 0 引用数: 0 h-index: 0机构: Univ Bari Aldo Moro, Dept Biomed Sci, Piazza Giulio Cesare 11, I-70124 Bari, Italy Univ Bari Aldo Moro, Human Oncol Hyg Sect, Piazza Giulio Cesare 11, I-70124 Bari, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, ItalySallustio, Anna论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Consorziale Policlin Bari, Piazza G Cesare 11, I-70124 Bari, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, ItalyPicca, Rosaria Anna论文数: 0 引用数: 0 h-index: 0机构: Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, ItalyFelici, Roberto论文数: 0 引用数: 0 h-index: 0机构: CNR SPIN, Area Ric Tor Vergata, Via Fosso Cavaliere 100, I-00133 Rome, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, ItalyChironna, Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Bari Aldo Moro, Dept Biomed Sci, Piazza Giulio Cesare 11, I-70124 Bari, Italy Univ Bari Aldo Moro, Human Oncol Hyg Sect, Piazza Giulio Cesare 11, I-70124 Bari, Italy Univ Bari Aldo Moro, Chem Dept, Via Orabona 4, I-70126 Bari, Italy论文数: 引用数: h-index:机构:
- [40] A single immunization with cellular vaccine confers dual protection against SARS-CoV-2 and cancerCANCER SCIENCE, 2022, 113 (08) : 2536 - 2547Shimizu, Kanako论文数: 0 引用数: 0 h-index: 0机构: RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, Japan RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, JapanUeda, Shogo论文数: 0 引用数: 0 h-index: 0机构: RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, Japan RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, JapanKawamura, Masami论文数: 0 引用数: 0 h-index: 0机构: RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, Japan RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, JapanSatoh, Mikiko论文数: 0 引用数: 0 h-index: 0机构: RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, Japan RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, JapanFujii, Shin-ichiro论文数: 0 引用数: 0 h-index: 0机构: RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, Japan RIKEN, Program Drug Discovery & Med Technol Platforms, Yokohama, Kanagawa, Japan RIKEN Ctr Integrat Med Sci, Lab Immunotherapy, Yokohama, Kanagawa, Japan